Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Berry Anderson and Mark George.
Berry Anderson
Connection Strength
2.654
Mark George
  1. A review of studies comparing methods for determining transcranial magnetic stimulation motor threshold: observation of movement or electromyography assisted. J Am Psychiatr Nurses Assoc. 2009 Oct; 15(5):304-13.
    View in: PubMed
    Score: 0.367
  2. Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
    View in: PubMed
    Score: 0.352
  3. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT. 2006 Mar; 22(1):49-53.
    View in: PubMed
    Score: 0.285
  4. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov; 28(11):973-80.
    View in: PubMed
    Score: 0.104
  5. Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: a randomized, controlled pilot study. Pain. 2011 Nov; 152(11):2477-2484.
    View in: PubMed
    Score: 0.103
  6. Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT. 2011 Mar; 27(1):5-10.
    View in: PubMed
    Score: 0.101
  7. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
    View in: PubMed
    Score: 0.101
  8. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
    View in: PubMed
    Score: 0.095
  9. Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology (Berl). 2010 Apr; 209(3):233-44.
    View in: PubMed
    Score: 0.094
  10. Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm (Vienna). 2009 Apr; 116(4):423-9.
    View in: PubMed
    Score: 0.087
  11. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.082
  12. Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimul. 2008 Jan; 1(1):44-51.
    View in: PubMed
    Score: 0.081
  13. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res. 2007 Aug; 94(1-3):332-41.
    View in: PubMed
    Score: 0.078
  14. Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry. 2007 May; 20(3):250-4; discussion 247-9.
    View in: PubMed
    Score: 0.077
  15. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
    View in: PubMed
    Score: 0.077
  16. Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT. 2006 Dec; 22(4):259-64.
    View in: PubMed
    Score: 0.075
  17. Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase. 2006 08; 12(4):216-20.
    View in: PubMed
    Score: 0.073
  18. Vagus nerve stimulation affects pain perception in depressed adults. Pain Res Manag. 2005; 10(1):9-14.
    View in: PubMed
    Score: 0.066
  19. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry. 2004 Apr 15; 55(8):816-25.
    View in: PubMed
    Score: 0.062
  20. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.
    View in: PubMed
    Score: 0.061
  21. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety. 2004; 20(2):98-100.
    View in: PubMed
    Score: 0.061
  22. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
    View in: PubMed
    Score: 0.057
  23. Decreased interhemispheric connectivity and increased cortical excitability in unmedicated schizophrenia: A prefrontal interleaved TMS fMRI study. Brain Stimul. 2020 Sep - Oct; 13(5):1467-1475.
    View in: PubMed
    Score: 0.048
  24. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
    View in: PubMed
    Score: 0.023
  25. Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT. 2009 Jun; 25(2):91-8.
    View in: PubMed
    Score: 0.022
  26. Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res. 2008 Apr; 101(1-3):142-51.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.